The Axcellant team recently traveled to New York to meet with research partners and clinical collaborators from across the U.S.
The visit included working sessions focused on upcoming trials and regulatory planning, as well as our AI-powered medical device project for the early detection of congenital heart defects. These conversations are helping shape the next steps in our clinical development roadmap.
We also continued preparations for opening our new U.S. office — a move that will strengthen our ability to work closely with sponsors and research teams in North America.
Beyond the meetings, the trip offered space for team reflection and strategic thinking — sometimes the best ideas come outside of meeting rooms.
Thank you to everyone who took the time to meet with us. We look forward to continuing the conversations and turning shared plans into action.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2025 Axcellant